Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: A systematic review and meta-analysis of randomized controlled trials

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 7, 2013, Pages 1018-1027

  Geeganage, Chamila M ^a,b   Sprigg, Nikola ^a,b   Bath, Matthew W ^a   Bath, Philip M W ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Acute ischemic stroke; anticoagulation; intracerebral hemorrhage; pulmonary embolism; thromboprophylaxis

Indexed keywords

CERTOPARIN; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; MESOGLYCAN; NADROPARIN; TINZAPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL SINUS THROMBOSIS; COCHRANE LIBRARY; EMBASE; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MEDLINE; META ANALYSIS; MORBID OBESITY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCISEARCH; SYMPTOMATIC PULMONARY EMBOLISM; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TIME TO TREATMENT; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ACUTE ISCHEMIC STROKE; ANTICOAGULATION; INTRACEREBRAL HEMORRHAGE; PULMONARY EMBOLISM; THROMBOPROPHYLAXIS;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; HEPARIN; HUMANS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84877927051     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.03.005     Document Type: Article

References (42)

1. P.W. Kamphuisen, G. Agnelli, and M. Sebastianelli Prevention of venous thromboembolism after acute ischemic stroke J Thromb Haemost 3 2005 1187 1194
2. P. Langhorne Measures to improve recovery in the acute phase of stroke Cerebrovasc Dis 9 1999 2 5
3. Antithrombotic Trialists Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
4. N. Sprigg, L.J. Gray, and P.M. Bath Compression stockings and the prevention of symptomatic venous thromboembolism: Data from the Tinzaparin in Acute Ischemic Stroke Trial J Stroke Cerebrovasc Dis 4 2005 203 209
5. S.V. Amaragiri, and T. Lees Elastic compression stockings for prevention of deep vein thrombosis Cochrane Database Syst Rev 3 2000 CD001484
6. M. Dennis, P.A. Sandercock, and J. Reid Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): A multicentre, randomised controlled trial Lancet 373 2009 1958 1965
7. P.M. Bath, and T.J. England Thigh-length compression stockings and DVT after stroke Lancet 373 2009 1923 1924
8. C. Mazzone, G.F. Chiodo, and P. Sandercock Physical methods for preventing deep vein thrombosis in stroke Cochrane Database Syst Rev 4 2004 CD001922
9. C. Kearon, and M. O'Donnell Should patients with stroke wear compression stockings to prevent venous thromboembolism? Ann Intern Med 153 2010 610 611
10. P.M. Bath, R. Iddenden, and F.J. Bath Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials Stroke 31 2000 1770 1778
11. G. Gubitz, P. Sandercock, and C. Counsell Anticoagulants for acute ischaemic stroke Cochrane Database Syst Rev 4 2004 CD000024
12. International Stroke Trial Collaborative Group The International Stroke Trial (IST); A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke Lancet 349 1997 1569 1581
13. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke JAMA 279 1998 1265 1272
14. P. Bath, E. Lindenstrom, and G. Boysen Tinzaparin in Acute Ischaemic Stroke (TAIST): A randomised aspirin-controlled trial Lancet 358 2001 702 710
15. P.A. Sandercock, C. Counsell, and A.K. Kamal Anticoagulants for acute ischaemic stroke Cochrane Database Syst Rev 4 2008 CD000024
16. M. Hommel The FISS bis Investigators Group Fraxiparine in ischaemic stroke study (FISS bis) Cerebrovasc Dis 8 Suppl 4 1998 19 [abstr]
17. H.P. Adams, G. del Zoppo, and M.J. Alberts Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an education tool for neurologists Stroke 38 2007 1655 1711
18. The European Stroke Association (ESO) Executive Committee and the ESO Writing Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 2008 457 507
19. National Institute for Health and Clinical Excellence web site Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital Available from: http://publications.nice.org. uk/venous-thromboembolism-reducing-the-risk-cg92 Accessed March 21, 2012
20. P.M. Bath Low molecular weight heparin in acute stroke Expert Opin Investig Drugs 7 1998 1323 1330
21. P.A. Sandercock, L.M. Gibson, and M. Liu Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack Cochrane Database Syst Rev 2 2009 CD000248
22. P.A. Sandercock, C. Counsell, and M.C. Tseng Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke Cochrane Database Syst Rev 3 2008 CD000119
23. P.A. Sandercock, C. Counsell, and G.J. Gubitz Antiplatelet therapy for acute ischaemic stroke Cochrane Database Syst Rev 3 2008 CD000029
24. A.F. Shorr, W.L. Jackson, and J.H. Sherner Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: A metaanalysis Chest 133 2008 149 155
25. British Medical Association Royal Pharmaceutical Society of Great Britain. British National Formulary 2010 BMJ Group and RPS Publishing London
26. J.P.T. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions 2008 Wiley Interscience London
27. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
28. M. Egger, G. Smith, and D. Altman Systematic Reviews in Health Care; Meta-analysis in Context 2nd ed. 2001 BMJ Publishing Group London, UK
29. D.G. Sherman, G.W. Albers, and C. Bladin The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomised comparison Lancet 369 2007 1347 1355
30. H.C. Diener, E.B. Ringelstein, and R. von Kummer Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the PROTECT trial Stroke 37 2006 139 144
31. W. Hacke, M. Kaste, and E. Bluhmki Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
32. M. Viitanen, B. Winblad, and K. Asplund Autopsy-verified causes of death after stroke Acta Med Scand 222 1987 401 408
33. R. Kay, K.S. Wong, and Y.L. Yu Low-molecular-weight heparin for the treatment of acute ischemic stroke N Engl J Med 333 1995 1588 1593
34. M. Hillbom, T. Erila, and K. Sotaniemi Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: A randomized, double-blind study Acta Neurol Scand 106 2002 84 92
35. M.H. Prins, R. Gelsema, and A.K. Sing Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients Haemostasis 19 1989 245 250
36. P.M. Sandset, T. Dahl, and M. Stiris A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke Semin Thromb Hemost 16 Suppl 1990 25 33
37. H.C. Diener, E.B. Ringelstein, and R. von Kummer Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators Stroke 32 2001 22 29
38. G. Cazzato, M. Zorzon, and G. Mase Mesoglycan in acute focal cerebral ischaemia [in Italian] Rev Neurol 59 1989 121 126
39. R. Dumas, F. Woitinas, and M. Kutnowski A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily Org 10172 and twice-daily low dose heparin in preventing deep-vein thrombosis in patients with acute ischemic stroke Age Ageing 23 1994 512 516
40. C. Hageluken, and J. Egberts A multi-centre, assessor-blind, randomized pilot study of three different doses of Org 10172 (375, 750 and 1250U), administered subcutaneously once daily, compared with low dose heparin, administered subcutaneously twice daily, in the prophylaxis of deep vein thrombosis (DVT) in patients with a non-haemorrhagic stroke of recent onset (protocol 85144) 1992 Organon International BV Oss, the Netherlands
41. J.C.J. Stiekema, J. Egberts, and J. Voerman An open, randomised, pilot multi-centre study of Org 10172 versus heparin administered for the purpose of deep vein thrombosis prophylaxis in patients with a non-haemorrhagic stroke of recent onset. Internal report SDGRR No. 2310 1988 Organon International BV Oss, the Netherlands
42. A.G.G. Turpie, M.N. Levine, and J. Hirsh Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke Lancet 1 1987 523 526